In the last trading session, 1.03 million Adaptive Biotechnologies Corp (NASDAQ:ADPT) shares changed hands as the company’s beta touched 1.78. With the company’s per share price at $9.20 changed hands at $0.15 or 1.66% during last session, the market valuation stood at $1.40B. ADPT’s last price was a discount, traded about -11.74% off its 52-week high of $10.28. The share price had its 52-week low at $2.99, which suggests the last value was 67.5% up since then.
Analysts gave the Adaptive Biotechnologies Corp (ADPT) stock a consensus recommendation rating of Hold, calculated at a mean rating of 1.25. If we narrow down to specifics, the data shows that 1 out of 11 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 6 recommended ADPT as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.
Adaptive Biotechnologies Corp (NASDAQ:ADPT) trade information
Instantly ADPT was in green as seen at the end of in last trading. With action -3.26%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 53.46%, with the 5-day performance at -3.26% in the red. However, in the 30-day time frame, Adaptive Biotechnologies Corp (NASDAQ:ADPT) is 25.51% up.
The consensus price target for the stock as assigned by Wall Street analysts is 14, meaning bulls need an upside of 34.29% from its current market value. According to analyst projections, ADPT’s forecast low is 5 with 18 as the target high. To hit the forecast high, the stock’s price needs a -95.65% plunge from its current level, while the stock would need to tank 45.65% for it to hit the projected low.
Adaptive Biotechnologies Corp (ADPT) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -1.51%. The 2025 estimates are for Adaptive Biotechnologies Corp earnings to increase by 22.63%, but the outlook for the next 5-year period is at 29.40% per year.
Adaptive Biotechnologies Corp (NASDAQ:ADPT)’s Major holders
RUBRIC CAPITAL MANAGEMENT LP holds the second largest percentage of outstanding shares, with 9.4971% or 14.0 million shares worth $50.68 million as of 2024-06-30.
Among Mutual Funds, the top two as of Apr 30, 2025 were ARK ETF Trust-ARK Genomic Revolution ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. With 5.96 shares estimated at $54.8 million under it, the former controlled 3.92% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.76% of the shares, roughly 4.2 shares worth around $38.62 million.
